文献速递胸部肿瘤放疗

Ki-67增殖指数与小细胞肺癌放疗反应的相关性

Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.
PubMed 文献 · Radiat Oncol · 2017-01-13

该回顾性研究纳入19例接受胸部放疗的小细胞肺癌患者,以79.77%为界将Ki-67增殖指数分为高、低两组。高Ki-67组完全缓解率为75.0%,低Ki-67组为27.3%,Ki-67指数与完全缓解率显著相关(P=0.05),高指数组完全缓解率显著更高(P=0.04)。两组中位生存时间无显著差异。

要点

  • 19例小细胞肺癌患者中,Ki-67≥79.77%组完全缓解率为75.0%,<79.77%组为27.3%。
  • Ki-67增殖指数与放疗后完全缓解率显著相关(P=0.05)。
  • 高Ki-67组完全缓解率显著高于低Ki-67组(P=0.04),但两组生存率无显著差异。

核心结论

  • 高Ki-67增殖指数可能预示小细胞肺癌对放疗更敏感,表现为更高的完全缓解率。
  • Ki-67增殖指数高低与患者生存率无显著差异。

研究设计与样本

  • 回顾性研究纳入19例接受胸部放疗的小细胞肺癌患者,临床分期采用UICC 2009 TNM系统(cstage IIA/IIB/IIIA/IIIB=3/1/7/8例)。
  • Ki-67采用免疫组化检测,增殖指数由e-Count软件测定;放疗总剂量45-60 Gy;19例中16例接受化疗。

主要发现

  • 以Ki-67增殖指数79.77%为界分组:≥79.77%为组1(8例),<79.77%为组2(11例)。
  • 放疗后组1完全缓解6例(75.0%),组2完全缓解3例(27.3%)。
  • Ki-67增殖指数与完全缓解率显著相关(P=0.05),组1完全缓解率显著高于组2(P=0.04)。
  • 全部患者中位生存时间为516天,组1与组2生存率无显著差异。

关键数值与推荐

  • Ki-67增殖指数分组界值为79.77%,≥79.77%为高指数组(8例),<79.77%为低指数组(11例)。
  • 放疗总剂量范围为45-60 Gy。

临床怎么用

  • Ki-67增殖指数可作为小细胞肺癌放疗敏感性的潜在预测指标,高指数患者可能更易获得完全缓解。
  • Ki-67指数不宜单独用于判断生存获益,需结合其他临床因素综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the breast cancer, the decision whether to administer adjuvant therapy is increasingly influenced by the Ki-67 proliferation index. In the present retrospective study, we investigated if this index could predict the therapeutic response to radiation therapy in small cell lung cancer (SCLC). METHODS: Data from 19 SCLC patients who received thoracic radiation therapy were included. Clinical staging was assessed using the TNM classification system (UICC, 2009; cstage IIA/IIB/IIIA/IIIB = 3/1/7/8). Ki-67 was detected using immunostained tumour sections and the Ki-67 proliferation index was determined using e-Count software. Radiation therapy was administered at total doses of 45-60 Gy. A total of 16 of the 19 patients received chemotherapy. RESULTS: Patients were divided into two groups, one with a Ki-67 proliferation index ≥79.77% (group 1, 8 cases) and the other with a Ki-67 proliferation index <79.77% (group 2, 11 cases). Following radiation therapy, a complete response (CR) was observed in six cases from group 1 (75.0%) and three cases from group 2 (27.3%). The Ki-67 proliferation index was significantly correlated with the CR rate (P = 0.05), which was significantly higher in group 1 than in group 2 (P = 0.04). The median survival time was 516 days for all patients, and the survival rates did not differ significantly between groups 1 and 2. CONCLUSIONS: Our study is the first to evaluate the correlation between the Ki-67 proliferation index and SCLC tumour response to radiation therapy. Our findings suggest that a high Ki-67 proliferation index might represent a predictive factor for increased tumour radiosensitivity.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ishibashi N, Maebayashi T, Aizawa T, et al. Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer. Radiat Oncol. 2017. PMID: 28086989. doi:10.1186/s13014-016-0744-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。